Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19

Lopinavir/ritonavir and arbidol have been previously used to treat acute respiratory syndrome- coronavirus 2 (SARS-CoV-2) replication in clinical practice; nevertheless, their effectiveness remains controversial. In this study, we evaluated the antiviral effects and safety of lopinavir/ritonavir and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhen, Lu, Zhaohui, Xu, Tianmin, Chen, Cong, Yang, Gang, Zha, Tao, Lu, Jianchun, Xue, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195393/
https://www.ncbi.nlm.nih.gov/pubmed/32283143
http://dx.doi.org/10.1016/j.jinf.2020.03.060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195393/
https://www.ncbi.nlm.nih.gov/pubmed/32283143
http://dx.doi.org/10.1016/j.jinf.2020.03.060

Ejemplares similares